← Every applicant
Senores Pharms FDA Approvals
16 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDENew drugSep 22, 2026TABLET, ORAL |
| DEFERIPRONENew drugDec 11, 2025TABLET, ORAL |
| GABAPENTINNew drugAug 7, 2025CAPSULE, ORAL |
| METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDENew drugJan 8, 2025TABLET, ORAL |
| IVERMECTINNew drugOct 16, 2024TABLET, ORAL |
| TOPIRAMATENew drugOct 10, 2024CAPSULE, ORAL |
| TIZANIDINE HYDROCHLORIDENew drugMay 13, 2024CAPSULE, ORAL |
| CHLORZOXAZONENew drugJan 22, 2024TABLET, ORAL |
| NICARDIPINE HYDROCHLORIDENew drugJul 17, 2023CAPSULE, ORAL |
| DICLOFENAC POTASSIUMNew drugMar 15, 2023TABLET, ORAL |
| BUTALBITAL AND ACETAMINOPHENNew drugApr 7, 2022TABLET, ORAL |
| KETOROLAC TROMETHAMINENew drugMar 23, 2022TABLET, ORAL |
| NYSTATINNew drugMar 10, 2022SUSPENSION, ORAL |
| MEXILETINE HYDROCHLORIDENew drugOct 1, 2021CAPSULE, ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINENew drugAug 13, 2021CAPSULE, ORAL |
| CHLORZOXAZONENew drugJul 29, 2021TABLET, ORAL |